연구성과로 돌아가기

2021 연구자 정보 (1041 / 1146)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Kang, Sae-Ryung
(Kang, SR) ⓘ 		Chonnam Natl Univ, Dept Nucl Med, Hwasun Hosp, 322 Seoyangro, Hwasun 519763, Jeollanamdo, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 81.4] Prognostic impact of ¹⁸F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment ⓘ SCIE ⓘ 81.4 HEMATOLOGY ⓘ shglory@hanmail.net; ⓘ
Kim, Hyeoung-Joon
(Kim, HJ) ⓘ 		Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, 322 Seoyangro, Hwasun 519763, Jeollanamdo, South Korea
Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Gwangju, South Korea
Chonnam Natl Univ, Hwasun Hosp, Genom Res Ctr Hematopoiet Dis, Jeollanam, South Korea
Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, Gwangju, Jeollanam Do, South Korea ⓘ 		JWP-9097-2024
Kim, Jungok ⓘ
ⓘ 		[JCR상위 81.4] Prognostic impact of ¹⁸F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment
[JCR상위 26.0] Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing
[JCR상위 1.9] Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease ⓘ 		SCIE ⓘ 1.9 HEMATOLOGY
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ⓘ 		shglory@hanmail.net;
zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca; ⓘ
Kim, Min Kyoung
(Kim, MK) ⓘ 		Yeungnam Univ, Dept Med, Coll Med, Daegu, South Korea ⓘ ACN-6827-2022
Kim, Min ⓘ
ⓘ 		[JCR상위 81.4] Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone ⓘ SCIE ⓘ 81.4 HEMATOLOGY ⓘ ckmin@catholic.ac.kr; ⓘ
Lee, Jae Hoon
(Lee, JH) ⓘ 		Gachon Univ, Dept Internal Med, Gil Hosp, Incheon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 81.4] Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone ⓘ SCIE ⓘ 81.4 HEMATOLOGY ⓘ ckmin@catholic.ac.kr; ⓘ
Lee, Je-Jung
(Lee, JJ) ⓘ 		Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, 322 Seoyangro, Hwasun 519763, Jeollanamdo, South Korea
Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Hwasun, South Korea
Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Gwangju, South Korea
Chonnam Natl Univ Hwasun Hosp, Dept Hematol Oncol, Yeosu, Jeollanam Do, South Korea
Chonnam Natl Univ, Sch Med, Yeosu, Jeollanam Do, South Korea
Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, Gwangju, Jeollanam Do, South Korea
Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Hwasun, Jeollanamdo, South Korea ⓘ 		F-6974-2013
JFA-4725-2023
Lee, Jung-Hye
Lee, Jeong ⓘ
ⓘ 		[JCR상위 81.4] Prognostic impact of ¹⁸F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment
[JCR상위 71.2] Real-world toxicity and efficacy of ixazomib, lenalidomide and dexamethasone in Asian RRMM patients supported by the patient assistance program
[JCR상위 71.2] Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT
[JCR상위 26.0] Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing
[JCR상위 13.7] Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and ¹⁸F-FDG PET/CT
[JCR상위 1.9] Development of a New Risk Stratification System for Patients with Newly Diagnosed Multiple Myeloma Using R-ISS and 18F-FDG PET/CT
[JCR상위 81.4] Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone ⓘ 		SCIE ⓘ 1.9 HEMATOLOGY
HEMATOLOGY;ONCOLOGY
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ⓘ 		shglory@hanmail.net;
zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
drjejung@chonnam.ac.kr;jhmoon@knu.ac.kr;
ckmin@catholic.ac.kr; ⓘ
Lee, Mark Hong
(Lee, MH) ⓘ 		Konkuk Univ, Sch Med, Med Ctr, Div Hematol Oncol,Dept Internal Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 81.4] Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone ⓘ SCIE ⓘ 81.4 HEMATOLOGY ⓘ ckmin@catholic.ac.kr; ⓘ
Lee, Yoojin
(Lee, YJ) ⓘ 		Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Daegu, South Korea
Univ Ulsan, Coll Med, Dept Hematol & Oncol, Ulsan Univ Hosp, Ulsan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 81.4] Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone ⓘ SCIE ⓘ 81.4 HEMATOLOGY ⓘ ckmin@catholic.ac.kr; ⓘ
Lim, Sung-Nam
(Lim, SN) ⓘ 		Haeundae Baek Hosp, Dept Internal Med, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 81.4] Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone ⓘ SCIE ⓘ 81.4 HEMATOLOGY ⓘ ckmin@catholic.ac.kr; ⓘ
Min, Jung-Joon
(Min, JJ) ⓘ 		Chonnam Natl Univ, Dept Nucl Med, Hwasun Hosp, 322 Seoyangro, Hwasun 519763, Jeollanamdo, South Korea
Chonnam Natl Univ, Sch Med, Yeosu, Jeollanam Do, South Korea
Chonnam Natl Univ, Hwasun Hosp, Dept Nucl Med, Yeosu, Jeollanam Do, South Korea ⓘ 		E-8074-2011
Hyun-Jung, Kim ⓘ
ⓘ 		[JCR상위 81.4] Prognostic impact of ¹⁸F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment
[JCR상위 13.7] Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and ¹⁸F-FDG PET/CT ⓘ 		SCIE ⓘ 13.7 HEMATOLOGY
HEMATOLOGY;ONCOLOGY ⓘ 		shglory@hanmail.net;
drjejung@chonnam.ac.kr;jhmoon@knu.ac.kr; ⓘ
Moon, Joon Ho
(Moon, JH) ⓘ 		교신저자 Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, 130 Dongdeok Ro, Daegu 41944, South Korea
Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Daegu, South Korea
Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Internal Med, Div Hematol Oncol,Sch Med, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med,Div Hematol Oncol, Daegu, South Korea
Kyungpook Natl Univ, Dept Hematol Oncol, Kyungpook Natl Univ Hosp, Sch Med, Daegu, South Korea
Kyungpook Natl Univ Hosp, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea
Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, Kyungpook Natl Univ, Daegu, South Korea ⓘ 		KFQ-2464-2024
Moon, Joonho ⓘ 		0000-0003-3756-796X
Moon, Joon-ho ⓘ 		Clinical impact of cell-free serum Epstein-Barr virus status in patients with newly diagnosed malignant lymphoma
[JCR상위 81.4] Prognostic impact of ¹⁸F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment
[JCR상위 5.8] Characterization of the novel DQA1*01:01:09 allele by next-generation sequencing
[JCR상위 72.4] Therapeutic strategies, including allogeneic stem cell transplantation, to overcome relapsed/refractory adult T-cell acute lymphoblastic leukemia
[JCR상위 72.4] Keeping a balance in chronic lymphocytic leukemia (CLL) patients taking ibrutinib: ibrutinib-associated adverse events and their management based on drug interactions
[JCR상위 43.9] Pediatric-inspired regimen with late intensifi- cation and increased dose of L-asparaginase for adult acute lymphoblastic leukemia: the KALLA 1406/1407 study
[JCR상위 71.2] Real-world toxicity and efficacy of ixazomib, lenalidomide and dexamethasone in Asian RRMM patients supported by the patient assistance program
[JCR상위 71.2] Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT
[JCR상위 26.0] Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing
[JCR상위 1.9] Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease
[JCR상위 13.7] Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and ¹⁸F-FDG PET/CT
[JCR상위 1.9] Development of a New Risk Stratification System for Patients with Newly Diagnosed Multiple Myeloma Using R-ISS and 18F-FDG PET/CT
[JCR상위 26.0] Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma
[JCR상위 7.4] Clonal hematopoiesis is associated with risk of severe Covid-19
[JCR상위 43.0] Clinical characteristics and prognostic factors of acquired haemophilia A in Korea ⓘ 		ESCI
SCIE ⓘ 		1.9 HEMATOLOGY
CELL BIOLOGY;IMMUNOLOGY;PATHOLOGY
MEDICINE, GENERAL & INTERNAL
HEMATOLOGY;ONCOLOGY
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION
MULTIDISCIPLINARY SCIENCES ⓘ 		jhmoon@knu.ac.kr;drydh1685@hotmail.com;
shglory@hanmail.net;
wondi@knu.ac.kr;
sksohn@knu.ac.kr;
jhmoon@knu.ac.kr;
zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
drjejung@chonnam.ac.kr;jhmoon@knu.ac.kr;
drydh1685@hotmail.com;wskimsmc@skku.edu;
bolton@wustl.edu;eskim@snubh.org;molder@unitel.co.kr;zehira@mskcc.org;
hemakim@yuhs.ac; ⓘ
Park, Hwa Kyung
(Park, HK) ⓘ 		Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, 322 Seoyangro, Hwasun 519763, Jeollanamdo, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 81.4] Prognostic impact of ¹⁸F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment ⓘ SCIE ⓘ 81.4 HEMATOLOGY ⓘ shglory@hanmail.net; ⓘ
Sohn, Sang Kyun
(Sohn, SK) ⓘ 		Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, 130 Dongdeok Ro, Daegu 41944, South Korea
Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, Daegu, South Korea
Kyungpook Natl Univ Hosp, Daegu, South Korea
Hallym Univ Sacred Heart Hosp, Dept Internal Med, Anyang, South Korea ⓘ
ⓘ
ⓘ 		Clinical impact of cell-free serum Epstein-Barr virus status in patients with newly diagnosed malignant lymphoma
[JCR상위 81.4] Prognostic impact of ¹⁸F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment
[JCR상위 72.4] Therapeutic strategies, including allogeneic stem cell transplantation, to overcome relapsed/refractory adult T-cell acute lymphoblastic leukemia
[JCR상위 72.4] Keeping a balance in chronic lymphocytic leukemia (CLL) patients taking ibrutinib: ibrutinib-associated adverse events and their management based on drug interactions
[JCR상위 43.9] Pediatric-inspired regimen with late intensifi- cation and increased dose of L-asparaginase for adult acute lymphoblastic leukemia: the KALLA 1406/1407 study
[JCR상위 1.9] Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease
[JCR상위 13.7] Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and ¹⁸F-FDG PET/CT
[JCR상위 1.9] Development of a New Risk Stratification System for Patients with Newly Diagnosed Multiple Myeloma Using R-ISS and 18F-FDG PET/CT
[JCR상위 4.5] Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial ⓘ 		ESCI
SCIE ⓘ 		1.9 HEMATOLOGY
MEDICINE, GENERAL & INTERNAL
HEMATOLOGY;ONCOLOGY ⓘ 		jhmoon@knu.ac.kr;drydh1685@hotmail.com;
shglory@hanmail.net;
sksohn@knu.ac.kr;
jhmoon@knu.ac.kr;
drjejung@chonnam.ac.kr;jhmoon@knu.ac.kr;
fravandi@mdanderson.org; ⓘ
Song, Ga-Young
(Song, GY) ⓘ 		Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, 322 Seoyangro, Hwasun 519763, Jeollanamdo, South Korea
Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Gwangju, South Korea
Chonnam Natl Univ, Med Sch, Hwasun Hosp, Dept Hematooncol, Jeollanamdo, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 81.4] Prognostic impact of ¹⁸F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment
[JCR상위 26.0] Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing
[JCR상위 26.0] Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma ⓘ 		SCIE ⓘ 26.0 HEMATOLOGY
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ⓘ 		shglory@hanmail.net;
zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
drydh1685@hotmail.com;wskimsmc@skku.edu; ⓘ
Yang, Deok-Hwan
(Yang, DH) ⓘ 		교신저자 Chonnam Natl Univ, Hwasun Hosp, Sch Med, Dept Hematol Oncol, 322 Seoyang Ro, Hwasun Eup 58128, Hwasun, South Korea
Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, 322 Seoyangro, Hwasun 519763, Jeollanamdo, South Korea
Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Gwangju, South Korea
Chonnam Natl Univ, Med Sch, Hwasun Hosp, Dept Hematooncol, Jeollanamdo, South Korea
Chonnam Natl Univ, Med Sch, Hwasun Hosp, Dept Hematooncol, Jeollanam Do, South Korea ⓘ
ⓘ
ⓘ 		Clinical impact of cell-free serum Epstein-Barr virus status in patients with newly diagnosed malignant lymphoma
[JCR상위 81.4] Prognostic impact of ¹⁸F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment
[JCR상위 26.0] Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing
[JCR상위 26.0] Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma
[JCR상위 43.0] Clinical characteristics and prognostic factors of acquired haemophilia A in Korea ⓘ 		ESCI
SCIE ⓘ 		26.0 HEMATOLOGY
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ⓘ 		jhmoon@knu.ac.kr;drydh1685@hotmail.com;
shglory@hanmail.net;
zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
drydh1685@hotmail.com;wskimsmc@skku.edu;
hemakim@yuhs.ac; ⓘ
Lee, Jung-Hoon
(Lee, JH) ⓘ 		제1저자 Kyungpook Natl Univ, Coll Nursing, 680 Gukchaebosang Ro, Daegu 41944, South Korea ⓘ
ⓘ 		0000-0001-9814-3285
Lee, Junghoon ⓘ 		[JCR상위 81.7] Nurses' Experiences of the COVID-19 Crisis ⓘ SCIE;SSCI ⓘ 81.7 NURSING ⓘ asansong@knu.ac.kr; ⓘ
페이지 이동: